Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0700
0.00 (0.00%)
Jul 3, 2024, 10:18 AM EDT - Market closed
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $11.88 million as of July 3, 2024. Its market cap has increased by 88.65% in one year.
Market Cap
11.88M
Enterprise Value
11.38M
1-Year Change
88.65%
Ranking
n/a
Category
Stock Price
$0.07
Market Cap Chart
Since July 5, 2019, Nascent Biotech's market cap has increased from $6.17M to $11.88M, an increase of 92.59%. That is a compound annual growth rate of 14.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2024 | 13.24M | -54.22% |
| Dec 29, 2023 | 28.92M | 20.99% |
| Dec 30, 2022 | 23.90M | 334.96% |
| Dec 31, 2021 | 5.49M | 150.09% |
| Dec 31, 2020 | 2.20M | -53.90% |
| Dec 31, 2019 | 4.77M | -22.74% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 847.90B |
| Novo Nordisk | 622.30B |
| UnitedHealth Group | 450.56B |
| Johnson & Johnson | 350.56B |
| Merck & Co. | 318.63B |
| AbbVie | 289.79B |
| AstraZeneca | 238.12B |
| Novartis AG | 208.78B |